Delivery Order SPE2DB20D1050-SPE2DB25FH93D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,563.72 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120 count), with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count units) valued at $2,707.41. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a $7,142.54 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,070.95 on July 29, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. As a delivery order, this award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $18,663.30 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,391.13 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count unit). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $1,072.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Contrave ER 8-90 mg on September 2, 2025, with completion scheduled for September 3, 2025. This non-set-aside award represents a single delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count), with a contract ceiling value of $1,654.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $6,744.98 for CONTRAVE ER 8/90MG 120 under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The award was made on September 18, 2025, with an ultimate completion date of October 16, 2025, and utilized no set-aside designation, indicating the contract was competitively awarded. This delivery order represents a...
- The Defense Logistics Agency awarded a $4,065.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count units) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a standard pharmaceutical supply transaction under the company's broader federal contract portfolio. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH93DDelivery Order
The Defense Logistics Agency awarded a $5,214.68 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, non-competitive award with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a child contract, this delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company's substantial IDC with the DLA enables it to supply a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Contrave, a weight-management medication, represents a routine procurement fulfilling medical supply needs through the established pharmaceutical prime vendor arrangement under the DLA Troop Support Medical contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/22/25 |